Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oligonucleotides to treat eye disease

Oligonucleotides to treat eye disease

US Patent 11123360 · Granted Sep 21, 2021

Estimated economic value: $11,959,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chemically modified single-stranded rna-editing oligonucleotides2025
Single-stranded RNA-editing oligonucleotides2024
Oligonucleotide therapy for Leber congenital amaurosis2024
Nucleic acid molecules for pseudouridylation2024
Chemically modified single-stranded RNA-editing oligonucleotides2023
Single-stranded RNA-editing oligonucleotides2023
Antisense oligonucleotides for the treatment of eye disease2022
Antisense oligonucleotides for the treatment of eye disease2022
Antisense oligonucleotides for the treatment of eye disease2022
Oligonucleotide complexes for use in RNA editing2022
Single-stranded RNA-editing oligonucleotides2021
Chemically modified single-stranded RNA-editing oligonucleotides2021